Nippon Kayaku To Increase Sales Five-fold Through Intravascular Cancer Drugs
This article was originally published in PharmAsia News
Executive Summary
Nippon Kayaku has prioritized cancer treatment through vascular injection as the new growth area, aiming to increase its sales five-fold to ¥10 billion by 2016 through new product launches